Literature DB >> 3881339

Comparative studies on adjuvanticity of Klebsiella O3 lipopolysaccharide and its lipid A and polysaccharide fractions.

N Kato, N Kido, M Ohta, S Naito.   

Abstract

Previously, we found that Klebsiella O3 lipopolysaccharide (KO3 LPS) exhibits very strong adjuvant activity in augmenting the delayed-type hypersensitivity and antibody responses to protein antigens, and also strong ability to enlarge the regional lymph node in mice. By hydrolysis in 1% acetic acid at 100 degrees for 1 hr, KO3 LPS was dissociated into 54-60% polysaccharide fraction and 25-27% lipid A fraction. The lipid A fraction thus prepared retained lethal toxicity for mice, whereas the polysaccharide fraction was essentially non-toxic. However, neither the lipid A fraction nor the polysaccharide fraction could reproduce the strong adjuvanticity of KO3 LPS, and a simple mixture of these two fractions also failed to do so. It is therefore concluded that, for expression of the strong adjuvanticity of KO3 LPS, both the lipid A and polysaccharide moieties are indispensable and must be combined in the form of LPS. By contrast, administration of relatively large amounts of the lipid A fraction alone could elicit enlargement of the regional lymph node to the same degree as that attained by KO3 LPS. The regional lymph node-enlarging activity of the lipid A fraction in lesser amounts was enhanced by addition of the polysaccharide fraction. It is therefore likely that there is no direct correlation between adjuvant activity of the LPS or its derivatives, and their regional lymph node-enlarging activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881339      PMCID: PMC1453489     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. VII. Further purification of the active substance.

Authors:  M Ohta; M Mori; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1979       Impact factor: 1.955

2.  Interaction of lipopolysaccharides and lipid A with complement.

Authors:  C Galanos; E T Rietschel; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1971-03-01

3.  Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens.

Authors:  M Ohta; I Nakashima; N Kato
Journal:  Cell Immunol       Date:  1982-01-01       Impact factor: 4.868

4.  The O9 antigen of Escherichia coli. Structure of the polysaccharide chain.

Authors:  P Prehm; B Jann; K Jann
Journal:  Eur J Biochem       Date:  1976-08-01

5.  Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. II. Relationships of intensity of the action to that of other immunological activities.

Authors:  M Ohta; I Nakashima; N Kato
Journal:  Immunobiology       Date:  1982-12       Impact factor: 3.144

6.  The Klebsiella O3 lipopolysaccharide isolated from culture fluid: structure of the polysaccharide moiety.

Authors:  T Hasegawa; M Ohta; M Mori; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1983       Impact factor: 1.955

7.  Ultrastructure of Klebsiella O3 lipopolysaccharide isolated from culture supernatant: structure of various uniform salt forms.

Authors:  N Kato; M Ohta; N Kido; S Naito; T Kuno
Journal:  Microbiol Immunol       Date:  1984       Impact factor: 1.955

8.  Further studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. II. Serological relationship between the adjuvant polysaccharide and O3 antigen of Klebsiella.

Authors:  N Kato; M Ohta; T Hasegawa; M Mori; K Yamaki; K Mizuta; I Nakashima; S Naito
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

9.  Further Studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. I. Production of the adjuvant polysaccharide by noncapsulated mutant.

Authors:  M Ohta; M Mori; T Hasegawa; F Nagase; I Nakashima; S Naito; N Kato
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

10.  Adjuvant action of capsular polysaccharide of Klebsiella pneumoniae on antibody response. VIII. Its effect on the size and the number of cells of regional lymph node and other lymphoid organs.

Authors:  T Yokochi; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

View more
  8 in total

1.  Adjuvant actions of linear mannan-possessing lipopolysaccharide (LPS) in LPS-resistant C3H/HeJ mice.

Authors:  M Ohta; N Kido; I Nakashima; N Kato
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

2.  Applications of polysaccharides. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1986-04       Impact factor: 2.926

3.  Crystallization of R-form lipopolysaccharides from Salmonella minnesota and Escherichia coli.

Authors:  N Kato; M Ohta; N Kido; H Ito; S Naito; T Hasegawa; T Watabe; K Sasaki
Journal:  J Bacteriol       Date:  1990-03       Impact factor: 3.490

4.  Marked reduction of mouse peritoneal CD5+ B cells by intraperitoneal administration of lipopolysaccharide.

Authors:  N Paeng; N Kido; Y Kato; T Sugiyama; N Koide; M Naruse; G Z Jiang; T Lwin; T Yoshida; T Yokochi
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

5.  The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity.

Authors:  A el-Roiey; O Sela; D A Isenberg; R Feldman; B C Colaco; R C Kennedy; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

6.  Retention of bacterial lipopolysaccharide at the site of subcutaneous injection.

Authors:  T Yokochi; Y Inoue; J Yokoo; Y Kimura; N Kato
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

7.  In vivo production of heat shock protein in mouse peritoneal macrophages by administration of lipopolysaccharide.

Authors:  Y H Zhang; K Takahashi; G Z Jiang; X M Zhang; M Kawai; M Fukada; T Yokochi
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

8.  Contribution of the mannan O side-chains to the adjuvant action of lipopolysaccharides.

Authors:  M Ohta; N Kido; T Hasegawa; H Ito; Y Fujii; Y Arakawa; T Komatsu; N Kato
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.